← Back to patent-cliff list
CAS 695171-91-6
tert-butyl (4-(2-oxoethyl)phenyl)carbamate
Codes：MIRA-018
Application context (from source-drug indications)
神经性膀胱功能障碍米拉贝隆膀胱过度活动症米拉贝隆
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 米拉贝隆Mirabegron | Tier B — Position early | 2029 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(2-aminothiazol-4-yl)acetic acid→(R)-2-((4-aminophenethyl)amino)-1-phenylethan-1-ol→2-(4-aminophenyl)ethanol→tert-butyl (4-(2-hydroxyethyl)phenyl)carbamate→tert-butyl (4-(2-oxoethyl)phenyl)carbamate→(R)-2-amino-1-phenylethanol→tert-butyl (R)-(4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.